Medicare Won't Pay for These Common Healthcare Costs in Retirement. Here's How to Get Them Covered

Medicare does not cover dental care, routine vision, or hearing aids, leaving beneficiaries to pay out-of-pocket unless they obtain additional coverage. Medicare Advantage plans often include these services but can be no cheaper, restrict enrollees to provider networks, and commonly require prior authorizations that delay care. The piece advises weighing alternatives (supplemental plans, HSAs, or higher retirement savings) and references a promotional claim that optimizing Social Security could boost income by up to $23,760 per year.

Analysis

Private insurers’ expanding role in managing senior care creates a material incremental demand vector for applied AI and edge compute — not just from cloud model training but from realtime inference needs (prior‑auth, triage imaging, telehealth stitching). Expect procurement cycles from large MA plans and their vendor ecosystems to favor GPUs and accelerators for the next 12–24 months as they chase margin recovery through automation and utilization management.

There is a bifurcation of winners: hyperscaler‑grade inference (NVDA) for centralized claims and imaging pipelines, and low‑power/ASIC/SoC suppliers (INTC and its foundry partners) for point‑of‑care devices, kiosks, and connected dental/optical hardware. The nonlinear second‑order effect is supplier consolidation: incumbents who can bundle device hardware + ML inference will grab share from pure software vendors, pressuring SaaS multiples but raising capital intensity for winners.

Policy and adoption risks are front‑loaded. A CMS policy expansion or targeted reimbursement for dental/vision/hearing within traditional Medicare would cut MA’s pricing leverage and slow private plan tech spend (12–36 month trigger). Conversely, a regulatory crackdown on prior‑auth delays would accelerate demand for automation and shorten payback on vendor deployments. The consensus underprices how quickly insurer tech budgets reallocate to compute-intensive automation once MA penetration stabilizes, creating an asymmetric window for tech suppliers while commoditization risk looms thereafter.

Key Decisions for Investors

• Initiate a tactical long on NVDA via a 9–12 month call spread sized to 1–2% portfolio: buy 25–30% OTM calls and sell 45–50% OTM calls (calendar: 9–12 months). Rationale: capture surge in inference demand from MA vendors; target asymmetric return (3:1 upside vs premium); stop‑loss at 50% premium loss.
• Add a convex small‑core position in INTC (2–3% portfolio) using 12–18 month LEAPS calls ~20–30% OTM. Rationale: play edge compute and SoC wins in clinics/dental devices where margin per unit justifies CPU/accelerator upgrades; risk: 20–30% draw if adoption lags, hedge with 0.5% portfolio put protection.
• Short GETY (or buy 9–12 month puts, size 1% portfolio) as a defensive trade against secular licensing pressure from consolidated insurer creative platforms and video/interactive budgets. Risk/reward: expect 20–40% downside if procurement centralization accelerates; keep stop at 15% adverse move.